Form 4: Abbott Laboratories Director Patricia Paola Gonzalez Reports Acquisition of Stock Equivalent Units

Director Patricia Paola Gonzalez reports acquisition of 290 stock equivalent units in Abbott Laboratories through director fees credited to a grantor trust.

Summary

• On March 31, 2024, Patricia Paola Gonzalez, a director of Abbott Laboratories, acquired 290 stock equivalent units.
• These units were obtained through director fees credited to a stock equivalent unit account under a grantor trust.
• The stock equivalent units earn the same return as if the fees were invested in Abbott shares and are generally paid in cash at age 65 or upon retirement from the board.
• The price of the stock equivalent units was $113.66.
• Following the transaction, Gonzalez directly owns 3,174 stock equivalent units, which includes units acquired through a dividend reinvestment feature.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (director compensation) and doesn't indicate any significant positive or negative sentiment. It's a neutral disclosure.

Positives

• The acquisition of stock equivalent units demonstrates the director's continued investment in Abbott Laboratories.
• The dividend reinvestment feature allows for further accumulation of stock equivalent units.

Industry Context

Directors commonly receive stock options or stock equivalent units as part of their compensation, aligning their interests with those of shareholders. This Form 4 filing reflects a standard practice in corporate governance.

Comparison to Industry Standards

• Director compensation packages often include stock-based compensation to incentivize long-term value creation.
• Companies like Johnson & Johnson (JNJ) and Pfizer (PFE) also utilize stock options and restricted stock units as part of their director compensation plans.
• The specific terms of these plans, such as vesting schedules and exercise prices, can vary widely based on company size, industry, and individual performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates